Structure-based development of new RAS-effector inhibitors from a combination of active and inactive RAS-binding compounds. (2019)
Attributed to:
Chromosomal translocation genes and their protein interactions in cancer
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1073/pnas.1811360116
PubMed Identifier: 30683716
Publication URI: http://europepmc.org/abstract/MED/30683716
Type: Journal Article/Review
Volume: 116
Parent Publication: Proceedings of the National Academy of Sciences of the United States of America
Issue: 7
ISSN: 0027-8424